Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

2015 ◽  
Vol 30 (7) ◽  
pp. 953-959 ◽  
Author(s):  
Sofia Reimão ◽  
Patrícia Pita Lobo ◽  
Dulce Neutel ◽  
Leonor Correia Guedes ◽  
Miguel Coelho ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Substantia Nigra ◽  
Mr Imaging ◽  
Essential Tremor

Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging

2013 ◽  
Vol 541 ◽  
pp. 93-98 ◽  
Author(s):  
Chigumi Ohtsuka ◽  
Makoto Sasaki ◽  
Kanako Konno ◽  
Mizuho Koide ◽  
Kanako Kato ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Substantia Nigra ◽  
Mr Imaging ◽  
Locus Coeruleus ◽  
Early Stage

Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study

2019 ◽  
Vol 26 (11) ◽  
pp. 1370-1376 ◽  
Author(s):  
G. Cardaioli ◽  
F. Ripandelli ◽  
F. Paolini Paoletti ◽  
P. Nigro ◽  
S. Simoni ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Longitudinal Study ◽  
Substantia Nigra ◽  
Essential Tremor ◽  
Substantia Nigra Hyperechogenicity

Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor

2016 ◽  
Vol 31 (4) ◽  
pp. 579-583 ◽  
Author(s):  
Fabienne S. Sprenger ◽  
Isabel Wurster ◽  
Klaus Seppi ◽  
Heike Stockner ◽  
Christoph Scherfler ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Substantia Nigra ◽  
Essential Tremor ◽  
Disease Risk ◽  
Substantia Nigra Hyperechogenicity

PO24-TH-29 Multimodal MR imaging of substantia nigra in Parkinson's disease

2009 ◽  
Vol 285 ◽  
pp. S293
Author(s):  
M. Zarei ◽  
R.A. Menke ◽  
J. Scholz ◽  
K. Miller ◽  
S. Deoni ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Substantia Nigra ◽  
Mr Imaging

scholarly journals 123-I ioflupane (Datscan®) presynaptic nigrostriatal imaging in patients with movement disorders

2005 ◽  
Vol 48 (spe2) ◽  
pp. 115-126 ◽  
Author(s):  
Angel Soriano Castrejón ◽  
Ana María García Vicente ◽  
Montserrat Cortés Romera ◽  
Julia Vaamonde Cano ◽  
Sonia Rodado Marina ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Substantia Nigra ◽  
Movement Disorder ◽  
Essential Tremor ◽  
Disease Progression ◽  
Movement Disorders ◽  
Neurodegenerative Disorders ◽  
Nigrostriatal Pathway

123-I Ioflupane (Datscan®) presynaptic imaging has been shown to have a significant utility in the assessment of patients with movement disorders 123-I Ioflupane SPECT is able to distinguish between Parkinson’s disease (PD) and other forms of parkinsonism without degeneration of the nigrostriatal pathway, including a common movement disorder such as essential tremor, and to assess disease progression in PD and other neurodegenerative disorders involving the substantia nigra.

Hyperechogenicity of substantia nigra in Parkinson's disease – Searching for genetic predictors

2008 ◽  
Vol 35 (S 01) ◽  
Author(s):  
C Funke ◽  
A Soehn ◽  
C Schulte ◽  
M Bonin ◽  
C Klein ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Substantia Nigra ◽  
Genetic Predictors
Sign in / Sign up

Export Citation Format

Share Document